Marea Therapeutics Appoints Shishir Gadam, Ph.D., as Chief Technical Officer
Dr. Gadam was most recently chief technical officer at Cargo Therapeutics and responsible for technical operations for the cell therapy portfolio. Prior to Cargo, he held the position of vice president and head of cell therapy global manufacturing sciences & technology at Juno therapeutics, a Celgene company and Bristol Myers Squibb where he was instrumental in launch of two cell therapy commercial CAR-T products. During his tenure at Genetech/Roche from 2006-2018, he held positions of increasing responsibility across technical development and manufacturing advancing multiple biologics programs. Dr. Gadam started his career at Merck & Company in developing bioprocesses for vaccines. He holds a Ph.D. in Biochemical Engineering from Rensselaer Polytechnic Institute, a M.S. in Chemical Engineering from West Virginia University and a B.S. in Chemical Engineering from the Institue of Chemical Technology, Mumbai, India.
'We are delighted to welcome Shishir to our senior leadership team,' said Josh Lehrer, M.D., M.Phil., FACC, chief executive officer of Marea Therapeutics. 'Shishir brings a remarkable track record of technical leadership across biologics, vaccines, and cell therapies, and his deep expertise in CMC and manufacturing operations will be instrumental as we advance our pipeline toward late-stage development. His proven ability to scale innovative therapies and build world-class technical capabilities will be invaluable as we prepare for Phase 3 readiness and continue to grow Marea into a leading cardioendocrine company.'
'I'm thrilled to join Marea at such an exciting moment in its growth,' said Dr. Gadam. 'The company's commitment to advancing first-in-class therapies for cardioendocrine diseases is both scientifically compelling and deeply meaningful. I look forward to working alongside this exceptional team to build and scale robust technical operations that will accelerate development and ultimately deliver transformative medicines to patients.'
About Marea Therapeutics
Marea Therapeutics is a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardioendocrine diseases. The company's lead therapy, MAR001, is in Phase 2 clinical development for adults with metabolic dysfunction and high risk for cardiovascular disease. The company is also advancing MAR002 for the treatment of acromegaly. To learn more, please visit www.mareatx.com and follow us on LinkedIn and X.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
9 minutes ago
- Business Wire
Bowhead Specialty Management to Present at the 2025 KBW Insurance Conference
NEW YORK--(BUSINESS WIRE)--Bowhead Specialty Holdings Inc. (the 'Company', 'Bowhead Specialty') (NYSE: BOW) announced today that Stephen Sills, Chief Executive Officer, and Brad Mulcahey, Chief Financial Officer, will participate in a fireside chat at the KBW Insurance Conference on September 3, 2025, in New York. The fireside chat will begin at approximately 2:50pm ET and will be webcast live. Management will also be available for one-on-one and small group meetings. The event details, webcast and our latest Investor Presentation can be found within the News & Events section of our Investor Relations website at About Bowhead Specialty Holdings Inc. Bowhead Specialty is a growing specialty insurance business providing casualty, professional liability and healthcare liability insurance products. We were founded and are led by industry veteran Stephen Sills. The team is composed of highly experienced and respected industry veterans with decades of individual, successful underwriting and management experience. We focus on providing 'craft' solutions in our specialty lines and classes of business that we believe require deep underwriting and claims expertise in order to produce attractive financial results. We pride ourselves on the quality and experience of our people, who are committed to exceeding our partners' expectations through excellent service and expertise. Our collaborative culture spans all functions of our business and allows us to provide a consistent, positive experience for all of our partners.
Yahoo
13 minutes ago
- Yahoo
Elon Musk's teen prodigy Kairan Quazi is ditching SpaceX for billionaire Ken Griffin's Citadel Securities
At just 16 years old, Kairan Quazi has already gained accolades most engineers spend decades accumulating. He graduated from college, helped design software for SpaceX Starlink satellites, and turned down offers from Silicon Valley's buzzy AI labs. Now, the prodigy is taking his next leap—not in Silicon Valley, but on Wall Street, where he's joining Citadel Securities, a liquidity provider, as a quant developer. A defiant attitude Quazi's path has been unconventional from the start. At 9, he left third grade for community college, went on to intern at Intel Labs at 10, and transferred to Santa Clara University at 11, eventually becoming the youngest graduate in its 172-year history. In 2023, he made headlines when Elon Musk's SpaceX hired him at just 14 years old. A 'rare company,' Quazi said at the time, that didn't use his age as an 'arbitrary and outdated proxy for maturity and ability.' The same year, he sparred with Microsoft-owned LinkedIn after it locked him out of the platform for being under 16, blasting the decision as 'illogical, primitive nonsense.' In fact, Quazi has never been shy about critiquing the traditional system that held him back. Once LinkedIn allowed him back on to their platform, Quazi posted a comment slamming the conventional school system. The 16-year-old argued that 'tests are not used to measure mastery, but the ability to regurgitate' and that the modern 'school factory' rewards fear and prestige-chasing over learning. 'Age, privilege, and unconscious (sometimes even conscious) biases are used to gatekeep opportunities,' he wrote, adding that philosophers like Seneca the Younger and Roman emperor Marcus Aurelius might have seen today's education system as dangerous. Two years later, Quazi is channeling that same defiance into a different arena. He turned down offers from top AI startups and tech firms to join Citadel Securities this week in New York, citing the firm's culture of meritocracy and instant feedback. 'Quant finance offers a pretty rare combination: the complexity and intellectual challenge that AI research also provides, but with a much faster pace,' he told Business Insider. At Citadel Securities he said, he'll be able to see the results of his work in 'days, not months or years.' A win-win Citadel Securities—sister company to the well-known Citadel—for its part, has every reason to trumpet the win. The firm, which handles roughly 35% of U.S. retail stock trades and generated nearly $10 billion in revenue in 2024, is locked in a talent war with the likes of OpenAI, Anthropic, and xAI. Recruiting a prodigy who was once deemed too young for LinkedIn—but now works at the intersection of engineering and quantitative problem-solving—is a symbolic coup for Ken Griffin's trading powerhouse. For Quazi, the move also closes a personal loop. His mother worked in mergers and acquisitions as an investment banker, giving him early exposure to finance. And on campus, he saw how coveted quant jobs had become for math and computer-science students. 'It's one of the most prestigious industries you could go into as a computer scientist or mathematician,' he told Business Insider. Now, he's living that reality in New York City. Quazi has moved into an apartment just a 10-minute walk from Citadel Securities' Park Avenue office. 'New York has a very special place in my heart,' he said, noting that his mom grew up in Astoria, Queens. Unlike his time at SpaceX, where his mother had to drive him to work in Redmond, Wash., Quazi's commute is now his own: first on foot, and soon, by subway. 'I felt ready to take on new challenges and expand my skill set into a different high-performance environment,' he said. 'Citadel Securities offered a similarly ambitious culture, but also a completely new domain, which is very exciting for me.' Jackie Scharnick, Citadel's communications director, said Quazi would pass on an interview with Fortune so he could 'focus on his second day of work.' This story was originally featured on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
24 minutes ago
- Business Wire
Small Medical Practices Are Sitting Ducks for Healthcare Cybercrime
SAN FRANCISCO--(BUSINESS WIRE)--Over 90% of U.S. healthcare providers operate as small organizations, yet a new Paubox report titled "What small healthcare practices get wrong about HIPAA and email security" reveals these practices are unknowingly exposing themselves to cyber attacks and federal compliance violations. 98% of small healthcare organizations falsely believe they're HIPAA compliant Share The study of 214 healthcare IT leaders and practice managers at organizations with fewer than 250 employees found that nearly all small practices (98%) claim their platforms "encrypt emails by default"—but most are using common tools like Microsoft 365 or Google Workspace that often fail to provide actual protection. "Nearly half of healthcare email breaches stem from Microsoft 365 alone," the survey found. The problem is that encryption may drop if a recipient's server doesn't support modern protocols, often without any alert to the sender—leaving protected health information completely exposed. The confidence crisis More than 80% of small practices expressed confidence in their current HIPAA compliance posture, but the reality is far different. The survey found widespread misconceptions that are creating massive compliance gaps: 83% believe patient consent removes the need for encryption—a costly misunderstanding. Federal regulations still require "appropriate safeguards" under the HIPAA Security Rule, even when patients agree to electronic communication. Getting a patient's okay to email doesn't eliminate the legal requirement for encryption and other protective measures. 64% believe patient portals are required for HIPAA compliance—yet the regulations say the opposite. HIPAA explicitly gives patients the right to request communication "by alternative means or at alternative locations, if reasonable." Portals are just one option among many, including secure direct email when proper safeguards are in place. 20% don't utilize any form of email archiving or audit trail—leaving one in five practices unable to investigate incidents after they happen or prove compliance during federal audits. These misconceptions create compliance violations that practices don't even realize exist, with healthcare providers unknowingly breaking federal law while genuinely believing they're following the rules. Cybercriminals target the vulnerable Phishing attacks—the leading cause of healthcare breaches—now account for over 70% of healthcare data breaches as of 2024. Small practices are prime targets because they typically lack dedicated security staff, formal training programs, or technical defenses. The survey found that 43% of small healthcare organizations reported experiencing a phishing or spoofing incident in the past year. Meanwhile, about 50% of these organizations lack anti-phishing controls beyond default spam filters, and nearly 99% have not implemented secure email transfer protocols. "Phishing attacks have evolved—they're faster, smarter, and relentless," noted Paubox CEO, Hoala Greevy. "It's not about one-off scams anymore; it's deception at scale." Beyond the breach When breaches occur, small practices face the same serious consequences as large health systems. Recent examples from the past year include: Solara Medical : $9.76 million class-action settlement following a phishing attack : $9.76 million class-action settlement following a phishing attack Sunrise Community Health : Email compromise affecting 54,000+ patients : Email compromise affecting 54,000+ patients Salud Family Health: Phishing attack exposing 80,000+ records Even smaller penalties come with major operational costs. Agape Health, a North Carolina clinic, paid $25,000 for emailing protected health information unencrypted to the wrong recipient, while Vision Upright MRI faced a $5,000 fine plus two years of federal monitoring after a server breach exposed over 21,000 individuals' medical imaging records. In 2025, healthcare breaches took an average of 224 days to detect and another 84 days to contain—over 10 months total. Without proper audit trails, many small organizations lack the systems to spot breaches until it's too late. Stretched thin and vulnerable The survey found that small healthcare practices are operating under dangerous constraints that create the perfect storm for security failures: One-third report not having enough time for compliance tasks—meaning critical security measures get pushed aside during busy patient care schedules. The same number have no clear policies or procedures in place, leaving staff to make up security protocols on the fly. Only half have phishing or spoofing protection enabled, despite facing the same sophisticated attacks that target major health systems. Meanwhile, the average small healthcare employee has access to more than 5,500 sensitive files—creating massive exposure when those unprotected phishing emails inevitably get through. This combination of time pressure, unclear guidance, and broad data access means a single clicked link can expose thousands of patient records. It's a vulnerability that cybercriminals are increasingly exploiting. What HIPAA investigators look for When HHS investigators arrive after a breach, they look for specific documentation that most small practices can't provide: Proof that protected health information was encrypted in transit—not just that platforms "support" encryption Audit logs showing who sent what to whom and whether it was properly protected Evidence of risk assessments documenting understood vulnerabilities Incident response procedures for when things go wrong "Every organization, no matter the size, is required to comply with the HIPAA Security Rule," emphasized Melanie Fontes Rainer, Director of the HHS Office for Civil Rights. "Risk assessments are not optional—they're foundational." The path forward With federal enforcement ramping up and cybercriminals increasingly targeting small practices, the window for voluntary compliance is closing fast. The practices that are getting ahead of this crisis share a common strategy: they've stopped relying on overworked staff to make perfect security decisions every time. Instead, they're implementing systems that encrypt every message automatically, maintain detailed audit trails without extra effort, and block phishing attacks before employees ever see them. "The cost of compliance is far less than the cost of a breach," the survey noted—and recent settlements prove it. At $25,000 to $9.76 million per incident, even "small" violations can devastate a practice's finances and reputation. For the 90% of healthcare providers operating as small organizations, the math is simple: invest in automated protection now, or face the much higher costs of breach response, federal penalties, and lost patient trust later. The choice is becoming less optional every day. The complete report, "What small healthcare practices get wrong about HIPAA and email security," is available for download at About Paubox Paubox is a leader in HIPAA compliant communication and marketing solutions for healthcare organizations. According to G2 rankings, Paubox leads the industry for Best Secure Email Gateway, Email Security, HIPAA Compliant Messaging Software, and Email Encryption solution, and is the only HIPAA compliant email company listed on G2's 2025 Best Healthcare Software Products. Paubox solutions include Paubox Email Suite, Paubox Marketing, Paubox Email API, Paubox Forms, and Paubox Texting. Launched in 2015, Paubox is trusted by over 7,000 healthcare organizations, including Cost Plus Drugs, Covenant Health, Devry University, and SimonMed Imaging.
